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The mutation Gly99lys (E99K) in the cardiac actin (ACTC) gene was reported
to cause Hypertrophic Cardiomyopathy in extensive clinical studies. Trans-
genic (TG) mice expressing 50% E99K mutant cardiac actin in their hearts
were generated and studied. The mice show high mortality between 28 and
45 days old (70% females, 34% males).
Thin filaments reconstituted with purified mouse f-actin from the survivors and
human heart tropomyosin and troponin were studied by in vitro motility assay.
The E99K thin filaments were 2.55 0.6 times more Ca2þ sensitive than NTG
thin filaments (p ¼ 0.05). E99K actin thin filaments also exhibited a reduced
response to troponin dephosphorylation (EC50 E99K/E99KdP ¼ 1.1 5 0.1
compared with 3.05 0.3 for NTG /NTGdP).
7 month-old E99K TG mice (n¼9) and their NTG littermates (n¼7) were
studied using in vivo cine MRI. Abnormal cardiac morphology and signif-
icantly lower ejection fractions (56.5 vs. 65.2%) and reduced stroke vol-
umes (26.0 vs. 42.3 ml) were observed in TG mice. Peak LV ejection
rates were also reduced (188 5 41 vs. 252 5 49 ml/min). LV mass
was similar between groups, but septal wall thickness was increased (1.5
vs. 1.0 mm).
Left ventricular function of 9 month-old female E99K NTG (n¼4) and TG
(n¼5) mice were studied with an in vivo conductance catheter. In TGmice ejec-
tion fraction was 20.2% less, end-diastolic pressure was 39.6% higher and
relaxation rate was 50.0% slower.
We conclude that the basic effect of E99K mutation is increased Ca2þ-sensitiv-
ity and blunted response to troponin dephosphorylation and this leads to the
high rate of sudden death at early ages, alterations to cardiac function and hy-
pertrophy as observed in patients with hypertrophic cardiomyopathy.
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At the myofilament level, increases in cardiac output in response to in-
creased sympathetic tone is achieved via protein kinase A (PKA)-mediated
phosphorylation of cardiac myosin binding protein C (cMyBP-C) and car-
diac troponin I (cTnI). However, despite the physiological importance of
b-adrenergic stimulation in maintaining cardiac performance, the respective
roles of cMyBP-C and cTnI phosphorylations in the myofibrillar force re-
sponse of working myocardium are not completely understood. Using trans-
genic mouse lines either (1) expressing mutant non-phosphorylatable cTnI
(cTnIala5) or (2) expressing cTnIala5 on a cMyBP-C null background
(cMyBP-C-/-/cTnIala5), we assessed the calcium sensitivity of force
(pCa50) and the rate of force redevelopment (ktr) in skinned myocardial
preparations following treatment with PKA and/or reconstitution with puri-
fied recombinant cMyBP-C. Before mechanical measurements, all prepara-
tions were treated with 2,3-butanedione monoxime (BDM) to reduce regu-
latory light chain (RLC) phosphorylation to near zero. In cTnIala5
myocardium, PKA phosphorylation of cMyBP-C resulted in a decrease in
pCa50 and an increase in ktr. However, no changes in either variable
were observed in cMyBP-C-/-/cTnIala5 myocardium in response to PKA
treatment. Following reconstitution of cMyBP-C-/-/cTnIala5 myocardium
with cMyBP-C, ktr decreased to the values observed in cTnIala5 myocar-
dium, demonstrating that incorporation of cMyBP-C slowed the rates of
cross-bridge attachment and transitions to strongly bound, force generating
states. Subsequent treatment of reconstituted cMyBP-C-/-/cTnIala5 myocar-
dium with PKA produced a rightward shift in pCa50 and an increase in
ktr. Together, these results suggest that in the absence of cTnI phosphory-
lation (and RLC phosphorylation), PKA phosphorylation of cMyBP-C de-
creases calcium sensitivity of force and speeds cross-bridge cycling kinetics
in murine myocardium.
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Cardiac myosin binding protein-C is a regulatory protein associated with sarco-
mere A-bands that modulates actomyosin interactions in a phosphorylation de-pendent manner. The MyBP-C motif, a highly conserved sequence in the N-ter-
minus of cMyBP-C, contains three to five protein kinase A (PKA)
phosphorylation sites, depending on species. In the human isoform, three PKA
sites have been identified (S275, S284, and S304). Three homologous sites exist
in the murine isoform (S273, S282, and S302) along with a potential fourth site,
S307, which is not present in human cMyBP-C. In this study, we investigated the
effects of PKA phosphorylation of murine cMyBP-C by treating a recombinant
protein, C1C2 (which contains the C1, motif, and C2 domains), with PKA and
assessing phosphorylation levels using IEF gels, ProQ Diamond staining, and
mass spectrometry. The wild-type C1C2 has a pI of ~8 and PKA treatment
(C1C2P) shifted the pI to ~5-6 as determined by 1-D IEF gels. A mutant
C1C2 (3S/D), containing aspartic acid for serine substitutions at S273D,
S282D, and S302D, was still phosphorylated upon treatment with PKA as in-
dicated by increased ProQ Diamond staining. However, a mutant 4S/D C1C2
(containing the additional mutation S307D) showed a pI near that of C1C2P
and was not further phosphorylated by PKA. Mass spectrometry and MASCOT
analysis of C1C2P confirmed that S307 was phosphorylated by PKA. These re-
sults suggest that murine S307 can be phosphorylated in vitro. Further studies
are needed to investigate the phosphorylation state of murine cMyBP-C in vivo.
Supported by NIH HL080367 to SPH and a NSF Graduate Research Fellowship
to JFS.
2578-Pos Board B548
Functional Effects of cMyBP-C Phospho-Mimics in Permeabilized Trabec-
ulae
Kristina L. Bezold, Justin F. Shaffer, Samantha P. Harris.
University of California, Davis, CA, USA.
Myosin Binding Protein C (MyBP-C) is a sarcomeric protein that has both
structural and regulatory roles in striated muscle contraction. Cardiac (c) iso-
forms of MyBP-C can be phosphorylated by protein kinase A (PKA) at three
to five sites within a unique regulatory region referred to as the MyBP-C
motif. We have previously shown, using permeabilized rat trabeculae, that
the recombinant protein C1C2, which contains the motif, significantly in-
creased Ca2þ sensitivity of force and increased rates of tension redevelop-
ment (ktr) at submaximal [Ca2þ]. To investigate whether these effects are
modulated by phosphorylation of the motif, we used the catalytic subunit
of PKA to phosphorylate C1C2. In addition, we used site directed mutagen-
esis to mutate three key serine residues (Ser273, 282, 302) to aspartic acids
to mimic phosphorylation at these sites. Results demonstrated that either
10uM phosphorylated C1C2 (C1C2P) or 10uM phospho-mimic C1C2
(C1C23S/D) increased Ca2þ sensitivity of force and increased rates of ten-
sion redevelopment (ktr) at submaximal [Ca2þ]. However, the phospho-
mimic C1C23S/D was more effective than C1C2P in producing these effects.
Together these results indicate that the 3 Ser to Asp phospho-mimic does not
fully mimic effects of PKA phosphorylation of C1C2 and that the functional
effects of C1C2 in permeabilized cardiac trabeculae are mediated at least in
part through phosphorylation-independent mechanisms. Supported by NIH
HL080367.
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Post-translational modification of troponin (Tn) and other myofilament proteins
by protein kinase C (PKC) isozymes plays a prominent role in regulating myo-
cardial contraction. Conventionally, phosphorylation of conserved serine and
threonine residues in the c-terminus activates PKCdelta, a novel calcium inde-
pendent isozyme. Several recent investigations including our work (Sumandea
et al. J Biol Chem. 2008;283(33):22680-9) have led to the probability of alter-
native activation of PKCdelta by tyrosine residue phosphorylation through a re-
dox-sensitive mechanism. Previous work determined PKCdelta phosphoryla-
tion of adult, cardiac rat myocytes in vitro reduces skinned myocyte tension
generation at sub-maximum with no change at maximum calcium concentra-
tions. Conversely, tyrosine phosphorylated PKCdelta reduces the maximal
Ca-activated tension with no decrease in submaximal tension production. Bio-
chemical data indicated a shift in TnI residue targeting with tyrosine phosphor-
ylated PKCdelta from exclusive phosphorylation of S23/24, to include T144.
To test the hypothesis that kinase targeting to TnI-T144 was sufficient to blunt
effects of conventional PKCdelta targeting to TnI-S23/24, myofibrillar function
was assessed following exchange of TnI with pseudo-phosphorylated residues.
Pseudo-phosphorylation at residues S23/24 decreased Ca-sensitivity of force
production and increased tension cost. Pseudo-phosphorylation at TnI-144
had minimal affect on mechanical parameters. However, the combination of
pseudo-phosphorylations at residues S23/24 and T144 did not successfully
blunt desensitization. Further biochemical assessments have determined
